Bristol-Myers Squibb Co. Logo

Bristol-Myers Squibb Co. (BMY)

BCBA

Currency in ARS
35,780.00
+160.00 (+0.45%)

Closed

Aug 24, 2026

Day's Range

35,480.00
35,800.00

52 wk Range

19,980.00
36,060.00

Profile - BMY - Bristol-Myers Squibb Co.

Profile

Mic Code

XBUE

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

32.50K


Bristol-Myers Squibb Co. is a globally renowned biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines. With a strong focus on serious diseases, the company's primary purpose is to address unmet medical needs in oncology, cardiovascular, immunoscience, and fibrosis through cutting-edge research and novel therapies. Bristol-Myers Squibb Co. is recognized for its portfolio of lifesaving medicines and commitment to patient-centric approaches, impacting various healthcare sectors including hospitals, private practices, and research institutions worldwide. The company's strategic collaborations and mergers, such as the notable acquisition of Celgene, have amplified its capabilities in biotechnology, bolstering its position as a leader in pharmaceuticals. Headquartered in New York City, Bristol-Myers Squibb Co. plays a pivotal role in the pharmaceutical market, steering advancements in medicine through continuous innovation and dedication to enhancing patient outcomes.

Profile Details

Type

Depositary Receipt

Ceo

Dr. Christopher S. Boerner Ph.D.

Address

Route 206 & Province Line Road

City

Princeton

State

NJ

Zip

08543

Country

United States

Phone

609 252 4621

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.